Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Aventis Pharma Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom Trading as: Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom
Buscopan 10 mg Tablets.
| Pharmaceutical Form |
|---|
|
Coated tablets. |
Each tablet contains hyoscine butylbromide 10 mg.
| Active Ingredient | Description | |
|---|---|---|
| Butylscopolamine |
Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs. |
| List of Excipients |
|---|
|
Tablet core: Calcium hydrogen phosphate Tablet coating: Sucrose |
Blister packs of 56, 100, 500 and 560.
Not all pack sizes may be marketed.
Aventis Pharma Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom
Trading as: Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom
PL 04425/0708
10.10.2014
| Drug | Countries | |
|---|---|---|
| BUSCOPAN | Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Finland, Hong Kong, Croatia, Ireland, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
